173 is the total number of securities ORACLE INVESTMENT MANAGEMENT INC has owned. The longest ORACLE INVESTMENT MANAGEMENT INC has owned a single stock is 42 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
OPK | OPKO HEALTH INC | 42 | 42 | 0.22% | 5.47% | 10.57% | Q2 2013 | Q3 2023 | 42 |
PACB | PACIFIC BIOSCIENCES CA... | 42 | 42 | 0.58% | 4.99% | 22.59% | Q2 2013 | Q3 2023 | 42 |
BIIB | BIOGEN INC | 42 | 42 | 0.08% | 0.33% | 0.65% | Q2 2013 | Q3 2023 | 42 |
QDEL | QUIDEL CORP | 36 | 36 | 7.82% | 20.04% | 52.48% | Q2 2013 | Q1 2022 | 36 |
AMRN | AMARIN CORP PLC | 31 | 31 | 0.51% | 5.87% | 23.09% | Q1 2014 | Q3 2021 | 31 |
VRML | VERMILLION INC | 28 | 28 | 0.58% | 2.15% | 3.77% | Q2 2013 | Q1 2020 | 28 |
AGEN | AGENUS INC | 22 | 1 | 0.48% | 3.27% | 9.79% | Q3 2013 | Q3 2023 | 25 |
TSRO | TESARO INC | 23 | 23 | 2.07% | 9.65% | 27.84% | Q2 2013 | Q4 2018 | 23 |
AXDX | ACCELERATE DIAGNOSTICS... | 21 | 1 | 0.74% | 9.17% | 23.04% | Q1 2014 | Q2 2023 | 23 |
MZOR | MAZOR ROBOTICS LTD | 20 | 20 | 3.13% | 8.22% | 17.98% | Q2 2013 | Q1 2018 | 20 |
BIOL | BIOLASE INC | 19 | 19 | 0.16% | 2.42% | 3.60% | Q3 2013 | Q1 2018 | 19 |
SLNO | SOLENO THERAPEUTICS INC | 19 | 19 | 0.09% | 1.11% | 2.74% | Q4 2017 | Q2 2022 | 19 |
CFRX | CONTRAFECT CORP | 19 | 19 | 0.18% | 0.86% | 2.71% | Q2 2015 | Q4 2019 | 19 |
AXK | ACCELR8 TECHNOLOGY INC | 11 | 3 | 5.80% | 16.77% | 24.62% | Q2 2013 | Q1 2018 | 18 |
ARAY | ACCURAY INC | 16 | 2 | 0.31% | 2.75% | 3.97% | Q2 2013 | Q4 2017 | 18 |
XON | INTREXON CORP | 18 | 18 | 0.04% | 2.47% | 5.24% | Q3 2013 | Q4 2017 | 18 |
NXTM | NXSTAGE MEDICAL INC | 17 | 17 | 4.62% | 8.67% | 13.48% | Q2 2013 | Q2 2017 | 17 |
AGEN | AGENUS INC | 11 | 1 | 0.44% | 1.46% | 3.75% | Q2 2013 | Q1 2018 | 17 |
BHVN | BIOHAVEN PHARMACTL HLD... | 15 | 15 | 2.00% | 25.04% | 54.93% | Q4 2018 | Q2 2022 | 15 |
BCRX | BIOCRYST PHARMACEUTICA... | 14 | 14 | 1.14% | 3.27% | 5.60% | Q2 2020 | Q3 2023 | 14 |
EYES | SECOND SIGHT MED PRODS... | 14 | 14 | 0.01% | 0.14% | 0.58% | Q4 2014 | Q1 2018 | 14 |
HNSN | HANSEN MEDICAL INC | 13 | 13 | 1.81% | 3.34% | 5.84% | Q2 2013 | Q2 2016 | 13 |
TTHI | TRANSITION THERAPEUTIC... | 13 | 13 | 1.24% | 2.73% | 4.63% | Q2 2013 | Q2 2016 | 13 |
MOTS | MOTUS GI HLDGS INC | 13 | 13 | 0.01% | 1.13% | 2.68% | Q4 2018 | Q4 2021 | 13 |
DERMTECH INC | 12 | 12 | 0.02% | 1.76% | 5.43% | Q4 2020 | Q3 2023 | 12 | |
MBLX | METABOLIX INC | 12 | 12 | 0.18% | 0.37% | 0.66% | Q2 2013 | Q1 2016 | 12 |
ACOR | ACORDA THERAPEUTICS INC | 11 | 11 | 3.30% | 7.06% | 11.36% | Q2 2013 | Q4 2015 | 11 |
AWH | ASPIRA WOMENS HEALTH INC | 11 | 11 | 0.13% | 3.37% | 8.74% | Q2 2020 | Q4 2022 | 11 |
FORA | FORIAN INC | 11 | 11 | 0.24% | 2.05% | 5.03% | Q1 2021 | Q3 2023 | 11 |
WBMD | WEBMD HEALTH CORP | 11 | 11 | 0.74% | 1.43% | 1.99% | Q2 2013 | Q4 2015 | 11 |
BIOL | BIOLASE INC | 11 | 11 | 0.06% | 1.26% | 3.13% | Q2 2018 | Q4 2020 | 11 |
ATRS | ANTARES PHARMA INC | 11 | 11 | 0.24% | 0.84% | 1.39% | Q3 2019 | Q1 2022 | 11 |
QDEL | QUIDEL CORP | 6 | 5 | 0.01% | 0.48% | 1.53% | Q4 2017 | Q4 2020 | 11 |
AXDX | ACCELERATE DIAGNOSTICS... | 9 | 2 | 0.02% | 0.23% | 0.66% | Q1 2017 | Q2 2020 | 11 |
THOR | THORATEC CORP | 10 | 10 | 0.06% | 6.90% | 11.89% | Q2 2013 | Q3 2015 | 10 |
IMMP | IMMUTEP LTD | 10 | 10 | 0.30% | 1.03% | 2.20% | Q2 2021 | Q3 2023 | 10 |
CFRX | CONTRAFECT CORP | 10 | 10 | 0.10% | 0.75% | 1.84% | Q1 2020 | Q2 2022 | 10 |
LTS | LADENBURG THALMAN FIN ... | 9 | 9 | 0.02% | 0.05% | 0.07% | Q2 2013 | Q2 2015 | 9 |
BHVN | BIOHAVEN PHARMACTL HLD... | 4 | 1 | 0.05% | 0.23% | 0.73% | Q1 2019 | Q3 2021 | 8 |
EPZM | EPIZYME INC | 7 | 7 | 0.07% | 0.90% | 1.70% | Q1 2017 | Q3 2018 | 7 |
YMAB | Y-MABS THERAPEUTICS INC | 7 | 7 | 0.13% | 0.78% | 1.72% | Q1 2020 | Q3 2021 | 7 |
AMRN | AMARIN CORP PLC | 6 | 1 | 0.00% | 0.24% | 1.44% | Q4 2018 | Q3 2020 | 7 |
VTNR | VERTEX ENERGY INC | 3 | 2 | 0.04% | 0.21% | 0.48% | Q2 2021 | Q3 2023 | 7 |
ZIOP | ZIOPHARM ONCOLOGY INC | 7 | 7 | 0.01% | 0.12% | 0.35% | Q2 2015 | Q4 2016 | 7 |
QUIDELORTHO CORP | 6 | 6 | 4.29% | 17.81% | 35.68% | Q2 2022 | Q3 2023 | 6 | |
CMRX | CHIMERIX INC | 6 | 6 | 1.14% | 4.44% | 7.71% | Q3 2014 | Q4 2015 | 6 |
ADAP | ADAPTIMMUNE THERAPEUTI... | 6 | 6 | 0.09% | 2.12% | 4.00% | Q3 2017 | Q4 2018 | 6 |
CDAK | CODIAK BIOSCIENCES INC | 6 | 6 | 0.41% | 1.08% | 1.73% | Q1 2021 | Q2 2022 | 6 |
GTXI | GTX INC DEL | 6 | 6 | 0.03% | 0.85% | 4.58% | Q2 2013 | Q3 2014 | 6 |
BIOHAVEN LTD | 5 | 5 | 4.85% | 12.90% | 33.68% | Q3 2022 | Q3 2023 | 5 | |
THC | TENET HEALTHCARE CORP COM | 3 | 1 | 8.59% | 10.46% | 14.16% | Q2 2013 | Q4 2014 | 5 |
MRTX | MIRATI THERAPEUTICS INC | 5 | 5 | 2.66% | 5.93% | 12.12% | Q2 2022 | Q2 2023 | 5 |
SEMA4 HOLDINGS CORP | 5 | 5 | 0.55% | 3.72% | 8.95% | Q1 2022 | Q1 2023 | 5 | |
IRWD | IRONWOOD PHARMACEUTICA... | 5 | 5 | 1.73% | 2.22% | 3.02% | Q2 2013 | Q2 2014 | 5 |
GTIV | GENTIVA HEALTH SERVICE... | 5 | 5 | 0.88% | 2.02% | 2.72% | Q2 2013 | Q2 2014 | 5 |
TQQQ | PROSHARES TR | 5 | 5 | 0.30% | 1.10% | 2.89% | Q2 2022 | Q2 2023 | 5 |
BDSX | BIODESIX INC | 4 | 1 | 0.02% | 0.38% | 0.72% | Q4 2020 | Q3 2023 | 5 |
TSRO | TESARO INC | 4 | 1 | 0.02% | 0.11% | 0.25% | Q1 2017 | Q2 2018 | 5 |
PACB | PACIFIC BIOSCIENCES CA... | 3 | 1 | 0.00% | 0.02% | 0.09% | Q3 2018 | Q4 2022 | 5 |
VIR | VIR BIOTECHNOLOGY INC | 4 | 4 | 3.46% | 4.89% | 6.40% | Q1 2021 | Q4 2021 | 4 |
DERM | DERMIRA INC | 4 | 4 | 2.88% | 4.41% | 7.20% | Q1 2019 | Q4 2019 | 4 |
ARDX | ARDELYX INC | 4 | 4 | 0.94% | 1.95% | 3.29% | Q4 2022 | Q3 2023 | 4 |
ARNA | ARENA PHARMACEUTICALS INC | 4 | 4 | 0.27% | 0.83% | 1.67% | Q3 2017 | Q2 2018 | 4 |
BHVN | BIOHAVEN PHARMACTL HLD... | 2 | 1 | 0.00% | 0.18% | 0.44% | Q3 2019 | Q1 2022 | 4 |
NXTM | NXSTAGE MEDICAL INC | 4 | 4 | 0.00% | 0.07% | 0.23% | Q1 2017 | Q4 2017 | 4 |
QUIDELORTHO CORP | 3 | 3 | 0.46% | 15.80% | 41.92% | Q1 2023 | Q3 2023 | 3 | |
MAKO | MAKO SURGICAL CORP | 3 | 3 | 0.62% | 2.21% | 4.01% | Q2 2013 | Q4 2013 | 3 |
RPRX | REPROS THERAPEUTICS INC | 3 | 3 | 1.39% | 2.19% | 2.66% | Q1 2014 | Q3 2014 | 3 |
RGLS | REGULUS THERAPEUTICS INC | 3 | 3 | 0.50% | 1.42% | 2.77% | Q1 2015 | Q3 2015 | 3 |
OMEGA THERAPEUTICS INC | 3 | 3 | 0.03% | 0.93% | 1.95% | Q1 2023 | Q3 2023 | 3 | |
SEM | SELECT MED HLDGS CORP | 3 | 3 | 0.52% | 0.78% | 1.15% | Q1 2021 | Q3 2021 | 3 |
DSCI | DERMA SCIENCES INC | 3 | 3 | 0.38% | 0.60% | 0.72% | Q1 2014 | Q3 2014 | 3 |
ADRO | ADURO BIOTECH INC | 3 | 3 | 0.18% | 0.41% | 0.54% | Q1 2018 | Q3 2018 | 3 |
AXK | ACCELERATE DIAGNOSTICS... | 3 | 3 | 0.15% | 0.29% | 0.50% | Q3 2017 | Q1 2018 | 3 |
MRTX | MIRATI THERAPEUTICS INC | 3 | 3 | 0.00% | 0.29% | 0.62% | Q2 2022 | Q4 2022 | 3 |
PFE | PFIZER INC | 1 | 1 | 0.01% | 0.27% | 0.46% | Q3 2021 | Q4 2022 | 3 |
SPY | SPDR S&P 500 ETF TR | 2 | 1 | 0.08% | 0.15% | 0.19% | Q3 2021 | Q3 2022 | 3 |
VIR | VIR BIOTECHNOLOGY INC | 2 | 1 | 0.03% | 0.15% | 0.22% | Q1 2021 | Q4 2021 | 3 |
BCRX | BIOCRYST PHARMACEUTICA... | 2 | 1 | 0.02% | 0.13% | 0.20% | Q3 2021 | Q3 2022 | 3 |
VELO3D INC | 2 | 1 | 0.01% | 0.12% | 0.19% | Q2 2022 | Q1 2023 | 3 | |
DERMTECH INC | 2 | 1 | 0.05% | 0.10% | 0.18% | Q1 2021 | Q1 2022 | 3 | |
OPK | OPKO HEALTH INC | 2 | 1 | 0.05% | 0.07% | 0.10% | Q2 2021 | Q1 2022 | 3 |
PTIX | PROTAGENIC THERAPEUTIC... | 3 | 3 | 0.00% | 0.06% | 0.12% | Q3 2021 | Q1 2022 | 3 |
AQB | AQUABOUNTY TECHNOLOGIE... | 3 | 3 | 0.01% | 0.02% | 0.02% | Q1 2017 | Q3 2017 | 3 |
AGEN | AGENUS INC | 1 | 1 | 0.00% | 0.00% | 0.01% | Q3 2020 | Q3 2022 | 3 |
PACIFIC BIOSCIENCES CA... | 2 | 2 | 5.05% | 14.18% | 23.30% | Q2 2023 | Q3 2023 | 2 | |
THC | TENET HEALTHCARE CORP | 1 | 1 | 8.58% | 9.45% | 10.32% | Q3 2013 | Q1 2014 | 2 |
BIOHAVEN LTD | 2 | 2 | 0.86% | 6.71% | 12.56% | Q2 2023 | Q3 2023 | 2 | |
RAPTOR PHARACEUTICALS | 2 | 2 | 3.70% | 4.58% | 5.45% | Q1 2015 | Q2 2015 | 2 | |
MRNA | MODERNA INC | 1 | 1 | 3.89% | 4.26% | 4.63% | Q2 2022 | Q4 2022 | 2 |
GENEDX HOLDINGS CORP | 2 | 2 | 1.11% | 2.46% | 3.80% | Q2 2023 | Q3 2023 | 2 | |
PFE | PFIZER INC | 2 | 2 | 0.25% | 1.19% | 2.14% | Q4 2021 | Q1 2022 | 2 |
CAPR | CAPRICOR THERAPEUTICS INC | 2 | 2 | 0.82% | 1.11% | 1.40% | Q1 2021 | Q2 2021 | 2 |
PTBI | PLASMATECH BIOPHARMACE... | 2 | 2 | 0.54% | 0.88% | 1.22% | Q4 2014 | Q1 2015 | 2 |
XBI | SPDR SER TR | 1 | 1 | 0.30% | 0.86% | 1.42% | Q2 2021 | Q3 2022 | 2 |
IBRX | IMMUNITYBIO INC | 1 | 1 | 0.44% | 0.67% | 0.89% | Q1 2022 | Q3 2022 | 2 |
CERS | CERUS CORP | 2 | 2 | 0.35% | 0.59% | 0.83% | Q4 2014 | Q1 2015 | 2 |
OPKO HEALTH INC | 2 | 2 | 0.30% | 0.34% | 0.38% | Q1 2023 | Q2 2023 | 2 | |
GILD | GILEAD SCIENCES INC | 2 | 2 | 0.01% | 0.26% | 0.50% | Q1 2014 | Q2 2014 | 2 |
BCRX | BIOCRYST PHARMACEUTICA... | 2 | 2 | 0.20% | 0.22% | 0.25% | Q4 2021 | Q1 2022 | 2 |
AVEO | AVEO PHARMACEUTICALS INC | 2 | 2 | 0.17% | 0.21% | 0.25% | Q2 2013 | Q3 2013 | 2 |
CNC | CENTENE CORP DEL | 2 | 2 | 0.08% | 0.18% | 0.29% | Q4 2021 | Q1 2022 | 2 |
PACB | PACIFIC BIOSCIENCES CA... | 1 | 1 | 0.02% | 0.05% | 0.08% | Q1 2021 | Q4 2021 | 2 |
QDEL | QUIDEL CORP | 1 | 1 | 0.04% | 0.05% | 0.05% | Q1 2021 | Q1 2022 | 2 |
MINK THERAPEUTICS INC | 2 | 2 | 0.01% | 0.04% | 0.08% | Q2 2023 | Q3 2023 | 2 | |
VTNR | VERTEX ENERGY INC | 1 | 1 | 0.02% | 0.02% | 0.03% | Q2 2022 | Q4 2022 | 2 |
SURGERY PARTNERS INC | 1 | 1 | 5.80% | 5.80% | 5.80% | Q2 2023 | Q2 2023 | 1 | |
PFE | PFIZER INC | 1 | 1 | 3.99% | 3.99% | 3.99% | Q4 2021 | Q4 2021 | 1 |
ARKK | ARK ETF TR | 1 | 1 | 3.28% | 3.28% | 3.28% | Q1 2022 | Q1 2022 | 1 |
MRNA | MODERNA INC | 1 | 1 | 3.05% | 3.05% | 3.05% | Q4 2022 | Q4 2022 | 1 |
BLUEPRINT MEDICINES CORP | 1 | 1 | 3.00% | 3.00% | 3.00% | Q2 2023 | Q2 2023 | 1 | |
RPTP | RAPTOR PHARMACEUTICAL ... | 1 | 1 | 2.68% | 2.68% | 2.68% | Q4 2014 | Q4 2014 | 1 |
QUIDELORTHO CORP | 1 | 1 | 2.24% | 2.24% | 2.24% | Q3 2023 | Q3 2023 | 1 | |
BPMC | BLUEPRINT MEDICINES CORP | 1 | 1 | 1.93% | 1.93% | 1.93% | Q2 2023 | Q2 2023 | 1 |
ECYT | ENDOCYTE INC | 1 | 1 | 1.82% | 1.82% | 1.82% | Q1 2014 | Q1 2014 | 1 |
AVIR | ATEA PHARMACEUTICALS INC | 1 | 1 | 1.35% | 1.35% | 1.35% | Q3 2021 | Q3 2021 | 1 |
MIRATI THERAPEUTICS INC | 1 | 1 | 1.33% | 1.33% | 1.33% | Q2 2023 | Q2 2023 | 1 | |
GH | GUARDANT HEALTH INC | 1 | 1 | 1.09% | 1.09% | 1.09% | Q3 2021 | Q3 2021 | 1 |
SWTX | SPRINGWORKS THERAPEUTI... | 1 | 1 | 1.08% | 1.08% | 1.08% | Q1 2023 | Q1 2023 | 1 |
CI | CIGNA CORP NEW | 1 | 1 | 1.00% | 1.00% | 1.00% | Q2 2019 | Q2 2019 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.90% | 0.90% | 0.90% | Q1 2022 | Q1 2022 | 1 |
BLUE | BLUEBIRD BIO INC | 1 | 1 | 0.84% | 0.84% | 0.84% | Q2 2014 | Q2 2014 | 1 |
THC | TENET HEALTHCARE CORP | 1 | 1 | 0.57% | 0.57% | 0.57% | Q4 2022 | Q4 2022 | 1 |
FIBROGEN INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q2 2023 | Q2 2023 | 1 | |
XBI | SPDR SER TR | 1 | 1 | 0.54% | 0.54% | 0.54% | Q2 2021 | Q2 2021 | 1 |
SGRY | SURGERY PARTNERS INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q2 2023 | Q2 2023 | 1 |
AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q1 2014 | Q1 2014 | 1 |
VRAY | VIEWRAY INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2018 | Q3 2018 | 1 |
PLTR | PALANTIR TECHNOLOGIES INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q2 2023 | Q2 2023 | 1 |
ABC | AMERISOURCEBERGEN CORP | 1 | 1 | 0.40% | 0.40% | 0.40% | Q4 2019 | Q4 2019 | 1 |
ELGX | ENDOLOGIX INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2017 | Q4 2017 | 1 |
MDGL | MADRIGAL PHARMACEUTICA... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2021 | Q3 2021 | 1 |
MNKD | MANNKIND CORP | 1 | 1 | 0.38% | 0.38% | 0.38% | Q3 2023 | Q3 2023 | 1 |
CENTENE CORP DEL | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2023 | Q1 2023 | 1 | |
LABU | DIREXION SHS ETF TR | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2022 | Q1 2022 | 1 |
BMY | BRISTOL MYERS SQUIBB CO | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2018 | Q1 2018 | 1 |
MNTA | MOMENTA PHARMACEUTICAL... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2015 | Q1 2015 | 1 |
CCRN | CROSS CTRY HEALTHCARE INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2021 | Q4 2021 | 1 |
PNT | POINT BIOPHARMA GLOBAL... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2022 | Q2 2022 | 1 |
NSTG | NANOSTRING TECHNOLOGIE... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2023 | Q3 2023 | 1 |
ACCELERATE DIAGNOSTICS... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2023 | Q3 2023 | 1 | |
VERTEX ENERGY INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2023 | Q1 2023 | 1 | |
TBIO | TRANSLATE BIO INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2020 | Q4 2020 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.21% | 0.21% | 0.21% | Q1 2022 | Q1 2022 | 1 |
MCKESSON CORP | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2023 | Q1 2023 | 1 | |
CANO | CANO HEALTH INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2022 | Q3 2022 | 1 |
MZOR | MAZOR ROBOTICS LTD | 1 | 1 | 0.17% | 0.17% | 0.17% | Q2 2018 | Q2 2018 | 1 |
TNXP | TONIX PHARMACEUTICALS ... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2014 | Q2 2014 | 1 |
ARKG | ARK ETF TR | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2021 | Q4 2021 | 1 |
VIR | VIR BIOTECHNOLOGY INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2021 | Q3 2021 | 1 |
QQQ | INVESCO QQQ TR | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2021 | Q3 2021 | 1 |
CARDINAL HEALTH INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2023 | Q1 2023 | 1 | |
DAY ONE BIOPHARMACEUTI... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2023 | Q1 2023 | 1 | |
XBIT | XBIOTECH INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2021 | Q4 2021 | 1 |
SERES THERAPEUTICS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2023 | Q1 2023 | 1 | |
SEM | SELECT MED HLDGS CORP | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2021 | Q1 2021 | 1 |
BIOHAVEN LTD | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2022 | Q4 2022 | 1 | |
LLY | LILLY ELI & CO | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2021 | Q3 2021 | 1 |
IWM | ISHARES TR | 1 | 1 | 0.08% | 0.08% | 0.08% | Q3 2022 | Q3 2022 | 1 |
ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2018 | Q2 2018 | 1 |
MNKD | MANNKIND CORP | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2013 | Q2 2013 | 1 |
MDGL | MADRIGAL PHARMACEUTICA... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2021 | Q3 2021 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2014 | Q3 2014 | 1 |
DB | DEUTSCHE BANK AG | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2019 | Q4 2019 | 1 |
XBIT | XBIOTECH INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
ABUS | ARBUTUS BIOPHARMA CORP | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2022 | Q1 2022 | 1 |
LXRX | LEXICON PHARMACEUTICAL... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2014 | Q4 2014 | 1 |
WBA | WALGREENS BOOTS ALLIAN... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2020 | Q4 2020 | 1 |
SEM | SELECT MED HLDGS CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 |
OPK | OPKO HEALTH INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2021 | Q3 2021 | 1 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2022 | Q2 2022 | 1 |
XBI | SPDR SERIES TRUST | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q3 2019 | 1 |
AGEN | AGENUS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q4 2021 | 1 |
Download |
The securities at the top of the list , including OPKO HEALTH INC, PACIFIC BIOSCIENCES CALIF IN, and BIOGEN INC, are the highest-conviction holdings of ORACLE INVESTMENT MANAGEMENT INC.
The conviction is calculated by counting the number of quarters a security has been reported by ORACLE INVESTMENT MANAGEMENT INC. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that ORACLE INVESTMENT MANAGEMENT INC owns currently or has owned in the past.